Usefulness of Metoclopramide to Improve Endoscopic Visualization in Upper

Status Recruiting

Clinical Trial Summary

A prospective, randomized, double-blind study will be conducted, including all patients with upper gastrointestinal bleeding, defined as vomiting blood or black bowel movements, within 12 hours prior to admission. Patients will be randomized to receive intravenous metoclopramide 20 mg or placebo, a placebo is a look-alike substance that contains no active drug. Then endoscopy will be performed in the following 120 minutes, evaluating endoscopic visualization with the modified Avgerinos scale.

Clinical Trial Description

A prospective, longitudinal, randomized, double-blind study will be carried out in which all patients who come to the University Hospital "Dr. José Eleuterio González" with upper gastrointestinal tract bleeding, defined in our study as hematemesis or melena, including patients with this condition in the 12 hours prior to admission. Patients will be randomized to receive metoclopramide 20 mg IV or placebo, this randomization will be performed by means of a computer sequence to receive each of the treatment sequences. Subsequently, the upper endoscopy will be performed in the following 120 minutes, and the endoscopic visualization will be evaluated by the physician performing the procedure by means of the modified Avgerinos scale; which gives a score of 0-2 according to the percentage of mucosal vision; 0= <25% visible surface, 1= 25%-75% visible surface and 2= >75% visible surface, evaluating fundus, body, antrum and bulb, a score ≥ 6 will be considered a clean stomach and a score ≤ 5 will be considered full stomach. The diagnosis of origin of the upper gastrointestinal tract bleeding will be determined by the physician in charge of performing the endoscopy. All cases will be filmed and another physician will review the cases and validate the Avgerinos score, as well as the final diagnosis reported. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06297954
Study type	Interventional
Source	Universidad Autonoma de Nuevo Leon
Contact	José Luis Herrera Elizondo, Physician
Phone	+528180182968
Email	here_herrera_11@hotmail.com
Status	Recruiting
Phase	Phase 3
Start date	March 16, 2023
Completion date	June 2024

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT02537353` - Trial of Hemospray Plus Epinephrine Injection Versus Endoscopic Hemoclip	Phase 4
Recruiting	`NCT03624517` - Comparison of 24-hours Versus 72-hours of Octreotide Infusion in Preventing Early Rebleed From Esophageal Varices	Phase 4
Suspended	`NCT03337256` - Direct Discharge of Patients With Upper Gastrointestinal Bleeding From the Emergency Department After Endoscopy	N/A
Completed	`NCT04472364` - HemoPill Acute ® in Suspected Nonvariceal Upper Gastrointestinal Bleeding	N/A
Completed	`NCT05563714` - Anticoagulation With Enhanced Gastrointestinal Safety	N/A
Recruiting	`NCT00414713` - Transfusion Requirements in Gastrointestinal (GI) Bleeding	Phase 4
Completed	`NCT03680950` - Efficacy Test of Real-Time Upper Gastrointestinal Monitoring System	N/A
Completed	`NCT05085405` - Anticoagulation With Enhanced Gastrointestinal Safety (AEGIS) Trial	N/A
Recruiting	`NCT06077916` - Gastric CLEANsing by Intravenous AZithromycin in Urgent Endoscopy	N/A
Recruiting	`NCT04902248` - OTSC vs. Angiographic Embolization in Patients With Refractory Non-variceal Upper Gastrointestinal Bleeding	N/A
Completed	`NCT02446678` - Use of PillCam ESO2 in Triaging Patients Present With Upper GIB	N/A
Completed	`NCT05631639` - Detection of Upper Gastrointestinal (GI) Bleeding Using a Novel Bleeding Sensor Capsule -A Pilot Study	N/A
Completed	`NCT02978391` - UI-EWD for Endoscopic Hemostasis of Bleeding Peptic Ulcers and Bleeding After EMR/ESD	N/A
Completed	`NCT00045799` - Safety & Efficacy of Omeprazole Sodium Bicarbonate for the Prevention of Upper GI Bleeding in the Critically Ill	Phase 3
Recruiting	`NCT03090945` - Pediatric Acute Gastrointestinal Bleeding Registry
Recruiting	`NCT06192355` - Single-use Versus Reusable Gastroscopes in Patients With Upper Gastrointestinal Bleeding.	N/A
Recruiting	`NCT03785080` - Non-warfarin Oral AntiCoagulant Resumption After Gastrointestinal Bleeding in Atrial Fibrillation Patients	N/A
Completed	`NCT03667703` - Stress Ulcer Prophylaxis Versus Placebo in Critically Ill Infants With Congenital Heart Disease	Phase 4
Terminated	`NCT02017379` - Randomized Control Trial Comparing Prokinetics and Their Influence on Endoscopy Outcomes for Upper GI Bleed.	N/A
Completed	`NCT01155401` - Study of Incidence of Drug-induced Upper Gastrointestinal Bleeding	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Usefulness of Metoclopramide to Improve Endoscopic Visualization in Upper Gastrointestinal Bleeding

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms